These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 16216995)
1. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Miller M; Zhan M; Havas S Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995 [TBL] [Abstract][Full Text] [Related]
2. [Study on C-reactive protein and the risk factors of traditional coronary heart disease]. Guo ZR; Hu XS; Chen FM; Wu M Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1064-8. PubMed ID: 18396656 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Hung J; Knuiman MW; Divitini ML; Davis T; Beilby JP Am J Cardiol; 2008 Jan; 101(2):193-8. PubMed ID: 18178405 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251 [TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975 [TBL] [Abstract][Full Text] [Related]
6. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012 [TBL] [Abstract][Full Text] [Related]
7. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260 [TBL] [Abstract][Full Text] [Related]
8. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Santos AC; Lopes C; Guimarães JT; Barros H Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717 [TBL] [Abstract][Full Text] [Related]
9. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity. Akbartabartoori M; Lean ME; Hankey CR Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein distribution and correlates among men and women with chronic coronary heart disease. Benderly M; Haim M; Boyko V; Tanne D; Behar S; Matas Z; Zimlichman R; Goldbourt U Cardiology; 2007; 107(4):345-53. PubMed ID: 17283424 [TBL] [Abstract][Full Text] [Related]
11. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677 [TBL] [Abstract][Full Text] [Related]
12. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Ford DE; Erlinger TP Arch Intern Med; 2004 May; 164(9):1010-4. PubMed ID: 15136311 [TBL] [Abstract][Full Text] [Related]
13. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002). Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376 [TBL] [Abstract][Full Text] [Related]
14. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study. Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508 [TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults. Bilhorn KR; Luo Y; Lee BT; Wong ND Am J Cardiol; 2012 Nov; 110(10):1464-7. PubMed ID: 22858184 [TBL] [Abstract][Full Text] [Related]
16. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Alley DE; Seeman TE; Ki Kim J; Karlamangla A; Hu P; Crimmins EM Brain Behav Immun; 2006 Sep; 20(5):498-504. PubMed ID: 16330181 [TBL] [Abstract][Full Text] [Related]
17. [C-reactive protein and homocysteine as risk factors of atherosclerosis]. Jarosz A; Nowicka G Przegl Lek; 2008; 65(6):268-72. PubMed ID: 18853656 [TBL] [Abstract][Full Text] [Related]
18. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. Kim SH; Chunawala L; Linde R; Reaven GM J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178 [TBL] [Abstract][Full Text] [Related]
20. Elevated C-reactive protein associated with decreased high-density lipoprotein cholesterol in men with spinal cord injury. Liang H; Mojtahedi MC; Chen D; Braunschweig CL Arch Phys Med Rehabil; 2008 Jan; 89(1):36-41. PubMed ID: 18164328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]